|
FASTKD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.646730E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.229900E-04 |
| Normal-vs-Stage2 |
2.733800E-02 |
| Normal-vs-Stage3 |
2.712500E-02 |
| Normal-vs-Stage4 |
5.570400E-04 |
| Stage1-vs-Stage2 |
7.102600E-01 |
| Stage1-vs-Stage3 |
6.311000E-01 |
| Stage1-vs-Stage4 |
2.697800E-01 |
| Stage2-vs-Stage3 |
9.678400E-01 |
| Stage2-vs-Stage4 |
2.315800E-01 |
| Stage3-vs-Stage4 |
2.376600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.384800E-04 |
| Normal-vs-AfricanAmerican |
1.304970E-03 |
| Normal-vs-Asian |
2.558800E-01 |
| Caucasian-vs-AfricanAmerican |
7.319400E-01 |
| Caucasian-vs-Asian |
5.783600E-01 |
| AfricanAmerican-vs-Asian |
6.581800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.63560000000196E-05 |
| Normal-vs-Female |
4.199000E-03 |
| Male-vs-Female |
2.992000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.187400E-04 |
| Normal-vs-Extreme_Weight |
7.07460000026749E-07 |
| Normal-vs-Obese |
6.137600E-03 |
| Normal-vs-Extreme_Obese |
6.672400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.103000E-01 |
| Normal_Weight-vs-Obese |
4.104400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.728100E-02 |
| Extreme_Weight-vs-Obese |
1.268050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.313190E-01 |
| Obese-vs-Extreme_Obese |
2.466800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.592180E-01 |
| Normal-vs-Age(41-60Yrs) |
7.360100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.767210E-04 |
| Normal-vs-Age(81-100Yrs) |
2.241300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.271800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.069600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.481800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.020200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.599700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.066200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55169999996419E-06 |
| Normal-VS-Type2 PRCC |
5.981300E-03 |
| Normal-VS-KIRP CIMP |
3.72110000002035E-06 |
| Normal-VS-Unclassified PRCC |
1.764410E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.501600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.203900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.702000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.498200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.321000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.383000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.968500E-04 |
| Normal-vs-N1 |
3.408000E-02 |
| Normal-vs-N2 |
1.922650E-03 |
| N0-vs-N1 |
4.685600E-01 |
| N0-vs-N2 |
1.617620E-01 |
| N1-vs-N2 |
1.258550E-01 |
|
|
